Projected Prevalence of Obesity in Primary Total Knee Arthroplasty: How Big Will the Problem Get?

医学 超重 体质指数 人口 行为危险因素监测系统 肥胖 物理疗法 现行程序术语 环境卫生 内科学 外科
作者
Christopher N. Carender,Natalie Glass,David E. DeMik,Jacob M. Elkins,Timothy S. Brown,Nicholas A. Bedard
出处
期刊:Journal of Arthroplasty [Elsevier]
卷期号:37 (7): 1289-1295 被引量:15
标识
DOI:10.1016/j.arth.2022.03.003
摘要

Obesity is a well-established risk factor for complications following primary total knee arthroplasty (TKA). The purpose of this study is to utilize 3 national databases to develop projections of obesity within the general population and primary TKA patients in the United States through 2029.Data from the National Surgical Quality Improvement Program (NSQIP), the Behavior Risk Factor Surveillance System (BRFSS), and the National Health and Nutrition Examination Survey were queried for years 1999-2019. Current Procedural Terminology code 27447 was used to identify primary TKA patients in NSQIP. Individuals were categorized according to body mass index (kg/m2) by year: normal weight (≤24.9); overweight (25.0-29.9); obese (30.0-39.9); and morbidly obese (≥40). Multinomial logistic regression was used to project categorical body mass index data for years 2020-2029.A total of 8,372,221 individuals were included (7,986,414 BRFSS, 385,807 NSQIP TKA). From 2011 to 2019, the prevalence of normal weight and overweight individuals declined in the general population (BRFSS) and in primary TKA. Prevalence of obese/morbidly obese individuals increased in the general population from 31% to 36% and in primary TKA from 60% to 64%. Projection models estimate that by 2029, 46% of the general population will be obese/morbidly obese and 69% of primary TKA will be obese/morbidly obese.By 2029, we estimate ≥69% of primary TKA to be obese/morbidly obese. Increased resources dedicated to care pathways and research focused on improving outcomes in obese arthroplasty patients will be necessary as this population continues to grow.Level III, Retrospective Cohort Study.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
浮浮世世发布了新的文献求助50
刚刚
zoloft完成签到,获得积分10
2秒前
忆韵完成签到,获得积分10
2秒前
susu完成签到,获得积分20
4秒前
隐形曼青应助YYJ25采纳,获得10
5秒前
5秒前
zoloft发布了新的文献求助10
6秒前
yhc完成签到,获得积分10
6秒前
季生发布了新的文献求助60
7秒前
老孙完成签到,获得积分10
8秒前
9秒前
汤浩宏完成签到,获得积分10
12秒前
12秒前
yudandan@CJLU发布了新的文献求助10
14秒前
Zkxxxx完成签到,获得积分10
14秒前
123完成签到,获得积分10
15秒前
大王卡完成签到,获得积分20
16秒前
16秒前
机智的紫丝完成签到,获得积分10
16秒前
TT发布了新的文献求助10
17秒前
田様应助啥,这都是啥采纳,获得10
20秒前
辛勤的孤容完成签到,获得积分10
21秒前
21秒前
21秒前
petrichor应助优美的跳跳糖采纳,获得1020
21秒前
科研通AI2S应助fleee采纳,获得10
21秒前
传奇3应助凝子老师采纳,获得10
22秒前
22秒前
22秒前
theverve完成签到,获得积分10
23秒前
ZJW完成签到,获得积分10
23秒前
完美世界应助bitahu采纳,获得10
23秒前
霸王龙完成签到,获得积分10
24秒前
26秒前
27秒前
YYJ25发布了新的文献求助10
27秒前
伯赏诗霜发布了新的文献求助50
28秒前
霸王龙发布了新的文献求助10
28秒前
ZJW发布了新的文献求助10
29秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527998
求助须知:如何正确求助?哪些是违规求助? 3108225
关于积分的说明 9288086
捐赠科研通 2805889
什么是DOI,文献DOI怎么找? 1540195
邀请新用户注册赠送积分活动 716950
科研通“疑难数据库(出版商)”最低求助积分说明 709849